Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
PAROLA trial: what clinicians have said so far
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
- NCT05581121 ↗
- Recruiting
- Institut Claudius Regaud
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on PAROLA (locally advanced cervical cancer; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on PAROLA so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 2 YouTube videos | |
| 1 post on X |
The trial
ClinicalTrials.gov- Official title
- PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Cervical Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
- Interventions
- Standard treatment: Control arm; Experimental arm
- Arms
- Arm A · Other
- Arm B · Experimental
- Enrollment
- 510 (estimated)
- Primary outcomes
- Disease Free Survival (DFS)
- Sponsor
- Institut Claudius Regaud with ARCAGY/ GINECO GROUP, European Network of Gynaecological Oncological Trial Groups (ENGOT), Gynecologic Cancer Intergroup (GCIG), Grupo Español de Investigación en Cáncer de Ovario, Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies, Belgian Gynaecological Oncology Group, Swiss GO Trial Group, Institute of Cancer Research, United Kingdom, The Central and Eastern European Gynecologic Oncology Group, Hellenic Cooperative Oncology Group
- Start
- Dec 20, 2023
- Primary completion
- Dec 20, 2033 (estimated)
- Results posted
- No
- Registry record
- NCT05581121 · updated Oct 13, 2026
Publications
linked from the registry- Martinez A, Lecuru F, Bizzarri N, Chargari C, Ducassou A, Fagotti A, Fanfani F, Scambia G, Cibula D, Diaz-Feijoo B, Gil Moreno A, Angeles MA, Muallem MZ, Kohler C, Luyckx M, Kridelka F, Rychlik A, Gerestein KG, Heinzelmann V, Ramirez PT, Frumovitz M, Ferron G, Betrian S, Filleron T, Fotopoulou C, Querleu D; PAROLA Study group. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. Int J Gynecol Cancer. 2023 Feb 6;33(2):293-298. doi: 10.1136/ijgc-2022-004223. PubMed 36717163